Works matching IS 09697128 AND DT 2002 AND VI 9 AND IP 4

Results: 9

High expression of transgenes mediated by hybrid retroviral vectors in hepatocytes: comparison of promoters from murine retroviruses in vitro and in vitro.
Published in:
Gene Therapy, 2002, v. 9, n. 4, p. 303, doi. 10.1038/sj.gt.3301655
By:
- Ohnishi, N.;
- Itoh, K.;
- Itoh, Y.;
- Baum, C.;
- Higashitsuji, H.;
- Yamaguchi, K.;
- Tsuji, T.;
- Okanoue, T.;
- Fujita, J.
Publication type:
Article
A tricistronic retroviral vector expressing natural antiangiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo.
Published in:
Gene Therapy, 2002, v. 9, n. 4, p. 297
By:
- Ciafre, S.A.;
- Barillari, G.;
- Bongiorno-Borbone, L.;
- Wannenes, F.;
- Izquierdo, M.;
- Farace, M.G.
Publication type:
Article
Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors vectors targeting tumor hypoxia/necrosis.
Published in:
Gene Therapy, 2002, v. 9, n. 4, p. 291, doi. 10.1038/sj.gt.3301659
By:
- Liu, S.-C.;
- Minton, N.P.;
- Giaccia, A.J.;
- Brown, J.M.
Publication type:
Article
Antibody-mediated lung endothelium targeting: in vivo model on primates.
Published in:
Gene Therapy, 2002, v. 9, n. 4, p. 282, doi. 10.1038/sj.gt.3301657
By:
- Balyasnikova, I.V.;
- Yeomans, D.C.;
- McDonald, T.B.;
- Danilov, S.M.
Publication type:
Article
Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signalling pathway.
Published in:
Gene Therapy, 2002, v. 9, n. 4, p. 270, doi. 10.1038/sj.gt.3301651
By:
- Fuerer, C.;
- Iggo, R.
Publication type:
Article
Tumour cell radiosensitisation using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapy.
Published in:
Gene Therapy, 2002, v. 9, n. 4, p. 263, doi. 10.1038/sj.gt.3301609
By:
- Worthington, J.;
- Robson, T.;
- O'Keeffee, M.;
- Hirst, D.G.
Publication type:
Article
Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv.
Published in:
Gene Therapy, 2002, v. 9, n. 4, p. 256, doi. 10.1038/sj.gt.3301639
By:
- Arafat, W.O.;
- Gomez-Navarro, J.;
- Buchsbaum, D.J.;
- Xiang, J.;
- Wang, M.;
- Casado, E.;
- Barker, S.D.;
- Mahasreshti, P.J.;
- Haisma, H.J.;
- Barnes, M.N.;
- Siegal, G.P.;
- Alvarez, R.D.;
- Hemminki, A.;
- Nettelbeck, D.M.;
- Curiel, D.T.
Publication type:
Article
Transduction of human neural progenitor cells using recombinant adeno-associated viral vectors.
Published in:
Gene Therapy, 2002, v. 9, n. 4, p. 245, doi. 10.1038/sj.gt.3301646
By:
- Wu, P.;
- Ye, Y.;
- Svendsen, C.N.
Publication type:
Article
A novel conditional Akt 'survival switch' reversibly protects cells from apoptosis.
Published in:
Gene Therapy, 2002, v. 9, n. 4, p. 233, doi. 10.1038/sj.gt.3301641
By:
- Li, B.;
- Desai, S.A.;
- MacCorkle-Chosnek, R.A.;
- Fan, L.;
- Spencer, D.M.
Publication type:
Article